Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  September 2014  »
MonTueWedThuFriSatSun
1234567
891011121314
15161718192021
22232425262728
2930 

Friends
    Links


    Entry 1 of 3135
    Last Page | Next Page
    3/17/2010 - Protalix BioTherapeutics commences clinical trial of human acetylcholinesterase for biodefense indications
    Posted in Medical News

    Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell denote pegylated recombinant human acetylcholinesterase product petitioner in growth for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers.

    More: - Read More

    Share |

    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb